JIANGSU AIDEA PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.78 CNY | -1.66% |
|
-3.40% | +18.15% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Jiangsu Aidea Pharmaceutical Co Ltd is a China-based company mainly engaged in the production and sales of human-source protein products. The Company is also engaged in the development and sales of some generic drugs, human immunodeficiency virus (HIV) diagnostic equipment and reagents. The Company is also engaged in the research and development of innovative drugs in anti-Acquired Immune Deficiency Syndrome (AIDS), anti-inflammatory and anti-tumor drugs fields. The Company's human-source protein products mainly include crude ulinastatin, crude urekline, crude urokinase and intermediates of ulinastatin. The Company mainly distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +18.15% | 874M | |
| -3.45% | 87.17B | |
| +2.76% | 40.1B | |
| -16.98% | 31.38B | |
| +57.86% | 25.12B | |
| -16.24% | 15.59B | |
| -9.12% | 12B | |
| -42.56% | 11.8B | |
| -17.10% | 11.8B | |
| +6.89% | 8.81B |
- Stock Market
- Equities
- 688488 Stock
- News Jiangsu Aidea Pharmaceutical Co., Ltd.
- Aidea Pharmaceutical, Subsidiaries Get Nod to Trial Anti-HIV Drug
